Trial intelligence / Profile preview

HCT vs Conventional Chemotherapy in Older AML Patients

NCT00766779Phase 3Terminated

Start
Jan 2010
Primary completion
Dec 2020
Countries
7
01

Overview

A Phase 3 trial of leuprolide in acute myeloid leukemia (AML). Started Jan 2010; status: terminated.

02

Drugs

leuprolide
03

Conditions

acute myeloid leukemia (AML)

Beyond the preview

Go deeper on NCT00766779.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00766779.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call